Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calvin J Meaney

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2025
Optimizing Comprehensive Medication Management in CKD: An Opportunity to Integrate Pharmacists in the Kidney Care TeamJoanna Q Hudson, Alex R Chang, Amanda J Condon Martinez, et al.
Journal of Clinical Pharmacology|June 25, 2021
Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant RecipientsDaniel Brazeau, Calvin J Meaney, Joseph D Consiglio, et al.
Journal of Clinical Pharmacology|May 8, 2019
Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal TransplantCalvin J Meaney, Patcharaporn Sudchada, Joseph D Consiglio, et al.
Pharmacotherapy|November 17, 2023
Urinary biomarkers as indicators of acute kidney injury in critically ill children exposed to vancomycinAutumn M Spyhalsky, Se Jin Kim, Calvin J Meaney, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin ExposureJustin R Lenhard, Tanya Brown, Michael J Rybak, et al.
Frontiers in Genetics|August 28, 2020
Beyond Single Nucleotide Polymorphisms: <i>CYP3A5</i> Composite and <i>ABCB1</i> Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant RecipientsDaniel A Brazeau, Kristopher Attwood, Calvin J Meaney, et al.
Pharmacotherapy|February 1, 2022
Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipientsKathleen M Tornatore, Calvin J Meaney, Kristopher Attwood, et al.
Kidney Medicine|August 22, 2022
Education Standards for Pharmacists Providing Comprehensive Medication Management in Outpatient Nephrology SettingsJoanna Q Hudson, Rebecca Maxson, Erin F Barreto, et al.
Medicine|September 17, 2015
Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 HaplotypesRocco C Venuto, Calvin J Meaney, Shirley Chang, et al.
Clinical Pharmacokinetics|December 17, 2014
Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipientsKathleen M Tornatore, Calvin J Meaney, Gregory E Wilding, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2025
Optimizing Comprehensive Medication Management in CKD: An Opportunity to Integrate Pharmacists in the Kidney Care TeamJoanna Q Hudson, Alex R Chang, Amanda J Condon Martinez, et al.
Journal of Clinical Pharmacology|June 25, 2021
Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant RecipientsDaniel Brazeau, Calvin J Meaney, Joseph D Consiglio, et al.
Journal of Clinical Pharmacology|May 8, 2019
Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal TransplantCalvin J Meaney, Patcharaporn Sudchada, Joseph D Consiglio, et al.
Pharmacotherapy|November 17, 2023
Urinary biomarkers as indicators of acute kidney injury in critically ill children exposed to vancomycinAutumn M Spyhalsky, Se Jin Kim, Calvin J Meaney, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin ExposureJustin R Lenhard, Tanya Brown, Michael J Rybak, et al.
Frontiers in Genetics|August 28, 2020
Beyond Single Nucleotide Polymorphisms: <i>CYP3A5</i> Composite and <i>ABCB1</i> Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant RecipientsDaniel A Brazeau, Kristopher Attwood, Calvin J Meaney, et al.
Pharmacotherapy|February 1, 2022
Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipientsKathleen M Tornatore, Calvin J Meaney, Kristopher Attwood, et al.
Kidney Medicine|August 22, 2022
Education Standards for Pharmacists Providing Comprehensive Medication Management in Outpatient Nephrology SettingsJoanna Q Hudson, Rebecca Maxson, Erin F Barreto, et al.
Medicine|September 17, 2015
Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 HaplotypesRocco C Venuto, Calvin J Meaney, Shirley Chang, et al.
Clinical Pharmacokinetics|December 17, 2014
Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipientsKathleen M Tornatore, Calvin J Meaney, Gregory E Wilding, et al.
Pageof 4